Thomas C. Südhof

Thomas C.
Südhof is the founder of Reata Pharmaceuticals, Inc. (2002), Circuit Therapeutics, Inc. (2011), and Neucyte, Inc. (2017).
Dr. Südhof is also the founder of Recognify Life Sciences, Inc. Dr. Südhof is currently an Independent Director at CytoDel LLC since 2021, a Member of The Royal Society since 2017, a Member of the National Academy of Sciences since 2002, a Member of the American Academy of Arts & Sciences since 2010, a Member of the National Academy of Medicine (United States) since 2007, a member of Deutsche Akademie der Naturforscher Leopoldina eV since 2015, a member of The Royal Norwegian Society For Development, a Professor at Stanford University School of Medicine, a Venture Partner at Catalio Capital Management LP, and a member of the Scientific Advisory Board at Alector, Inc., Elysium Pharmaceuticals Ltd., and Jupiter Therapeutics, Inc. Former positions include Independent Director at Abide Therapeutics, Inc. (2019-2020), Independent Director at Sanofi (2016-2024), Member-Neuroscience Review Board at Genentech, Inc. (2013-2016), and Assistant Professor at The University of Texas Southwestern Medical Center (1983-2008).
Education includes a doctorate from RWTH Aachen University and an undergraduate degree from the University of Gottingen.